Caption Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.87M Buy
6,400
+4,250
+198% +$1.4M 0.01% 839
2025
Q4
$754K Sell
2,150
-1,000
-32% -$338K 0.01% 1150
2025
Q3
$1.02M Buy
+3,150
New +$980K 0.01% 1100
2025
Q1
Sell
-7,065
Closed -$2.61M 1657
2024
Q4
$2.61M Buy
+7,065
New +$2.96M 0.02% 607
2024
Q3
Sell
-300
Closed -$163K 1371
2024
Q2
$163K Buy
+300
New +$159K ﹤0.01% 981
2020
Q3
Sell
-19,000
Closed -$5M 1086
2020
Q2
$5M Buy
+19,000
New +$5.07M 0.17% 164

Other funds holding ELV

Caption Management's ELV Position: Q1 2026 in Review

Caption Management increased its Elevance Health (ELV) stake by 198% in Q1 2026, buying an estimated $1.4M and bringing the position to 6,400 shares worth $1.87M. The position accounts for 0.01% of the portfolio, ranked #839.

Caption Management first reported a position in ELV in Q2 2020 and has held it in 6 quarters since. The position peaked at $5M in Q2 2020. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Caption Management held 6,400 shares of Elevance Health worth $1.87M as of Q1 2026.
  • Caption Management bought 4,250 Elevance Health shares in Q1 2026, an estimated $1.4M.
  • Elevance Health made up 0.01% of Caption Management's portfolio in Q1 2026, its #839 holding.
  • Caption Management first reported a position in Elevance Health in Q2 2020 and has held it in 6 quarters since.
  • Caption Management's Elevance Health position peaked at $5M in Q2 2020.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.